Suppr超能文献

载有癌细胞膜的纳米凝胶作为一种氧化还原/pH 双重响应的药物载体用于肿瘤靶向治疗。

Cancer cell membrane-coated nanogels as a redox/pH dual-responsive drug carrier for tumor-targeted therapy.

机构信息

Research Center of Blood Transfusion Medicine, Ministry of Education Key Laboratory of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, China.

School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China.

出版信息

J Mater Chem B. 2021 Oct 6;9(38):8031-8037. doi: 10.1039/d1tb00788b.

Abstract

Nanocarriers have shown great advantages in increasing the efficiency of drug delivery and reducing drug side effects. However, their lack of targeting and on-demand drug release abilities will seriously limit their clinical application. Herein, we report tumor cell membrane coated nanogels (NGs) with redox/pH dual-responsive behavior for enhanced tumor chemotherapy. The cell membrane coating improves the tumor targeting efficiency, and stimuli-responsive drug release enhances the therapeutic effects. These NGs are well dispersed in PBS with an average size of 109.1 ± 5.2 nm and a narrow polydispersity index of 0.12. Both and studies indicate that these NGs can responsively release the therapeutic drug DOX under acidic conditions or high GSH concentrations and effectively inhibit tumor growth. Based on the results, this nanogel shows promise as a platform for tumor-targeted chemotherapy for future clinical translation.

摘要

纳米载体在提高药物递送效率和降低药物副作用方面显示出巨大的优势。然而,它们缺乏靶向性和按需药物释放能力,这将严重限制其临床应用。在此,我们报道了具有氧化还原/pH 双重响应行为的肿瘤细胞膜包覆的纳米凝胶(NGs),用于增强肿瘤化学治疗。细胞膜包覆提高了肿瘤靶向效率,而刺激响应性药物释放增强了治疗效果。这些 NGs 在 PBS 中分散良好,平均粒径为 109.1 ± 5.2nm,多分散指数为 0.12。和 研究均表明,这些 NGs 可以在酸性条件或高 GSH 浓度下响应性地释放治疗药物 DOX,并有效抑制肿瘤生长。基于这些结果,该纳米凝胶有望成为未来临床转化的肿瘤靶向化疗的平台。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验